| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
| Su | Mo | Tu | We | Th | Fr | Sa |
|---|---|---|---|---|---|---|
-
Jun 1, 2001
The Perrigo Company (NASDAQ: PRGO) today announced that it will shortly begin shipping Famotidine 10 mg tablets through an agreement with Teva Pharmaceutical Industries Ltd. The terms of the...
-
Jun 1, 2001
The Perrigo Company (NASDAQ: PRGO) today announced an agreement to purchase Wrafton Laboratories Ltd., a subsidiary of McBride plc (LONDON: MCB) for $44 million. Wrafton Laboratories is a supplier...
-
May 18, 2001
The Perrigo Company (NASDAQ: PRGO) today announced that its presentation scheduled for Wednesday, May 23, 2001 at 8 a.m. EDT at the UBS Warburg Global Specialty Pharmaceuticals Conference in New...
-
May 1, 2001
Perrigo Company (NASDAQ: PRGO) today announced results for the third quarter and nine months ended March 31, 2001. Net sales for the quarter were $192.0 million, an increase of four percent...
-
Apr 25, 2001
Perrigo Company (NASDAQ: PRGO) today announced that it will release financial results for its fiscal 2001 third quarter ended March 31, 2001, on Tuesday, May 1, 2001 at approximately 8:30 a.m....